Sclerotherapy is an alternative for the treatment of oral vascular lesions; Polidocanol is one of the most commonly used sclerosing agents. Despite being used for decades in the literature there…
Aim: The cemento-ossifying fibroma (COF) is a benign fibro-osseous neoplasm of non-odontogenic origin, that is preferentially localised on the molar and premolar mandibular area. Our goal is to present cases…
Objects: Sentinel lymph node biopsy (SLNB) for cN0 early oral cancer has been validated by numerous studies. Around 30% of SNLB will detect occult disease. Several clinical and histopathological features…
Neoplasms that are derived from the odontogenic apparatus are rare and constitute a heterogeneous group of lesions. They have a specific histological structure that reflects various stages of odontogenesis and…
Osteoblastoma is a benign neoplasm representing approximately 1% of all primary bone tumors. The clinical aspects of the lesion are slow growth swelling, pain, bone expansion and eventual dental displacement….
Some tropical diseases have an endemic incidence on Latin American population, because of the weather and environment conditions typical of these places. Between these diseases paracoccidioidomycosis is a deep mycosis…
Introduction: There have been many techniques described to reconstruct segmental mandibulectomies. The free iliac crest flap provides an excellent bone height to place immediate dental implants. The drawback is the…
Fibro-osseous lesions are benign mesenchymal skeletal tumors in which mineralized tissue, blood vessels and giant cells, in varying proportions, re-place normal bone. Ossifying fibroma (OF) is often circumscribed lesion surrounded…
The melanotic neuroectodermal tumor of infancy (MNTI) is a rare neoplasm that affects mainly the anterior aspect of the maxilla during the first year of life. Although the MNTI is…
Langerhans cell histiocytosis (LCH) is a neoplastic proliferation of Langerhans cells. Its incidence is less than 1% of all bone lesions and occurs more frequently in people under 30 years…
